Novartis Ag (NVS) Free Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,827.56% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-56.64% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
154.57% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
149.74% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
50.71% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
46.82% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
23.04% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-55.31% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
36.22% |
| Dec 31, 2025 |
-92.09% |
| Sep 30, 2025 |
10.28% |
| Jun 30, 2025 |
36.22% |
| Mar 31, 2025 |
11.89% |
| Dec 31, 2024 |
10.94% |
| Sep 30, 2024 |
22.99% |
| Jun 30, 2024 |
35.10% |
| Mar 31, 2024 |
35.12% |
| Dec 31, 2023 |
21.52% |
| Sep 30, 2023 |
18.10% |
| Jun 30, 2023 |
-5.26% |
| Mar 31, 2023 |
-34.63% |
| Dec 31, 2022 |
-15.06% |
| Sep 30, 2022 |
-37.04% |
| Jun 30, 2022 |
-9.90% |
| Mar 31, 2022 |
4.47% |
| Dec 31, 2021 |
-4.11% |
| Sep 30, 2021 |
25.81% |
| Jun 30, 2021 |
6.05% |
| Mar 31, 2021 |
3.80% |
| Dec 31, 2020 |
1,420.61% |
| Sep 30, 2020 |
-21.85% |
| Jun 30, 2020 |
23.86% |
| Mar 31, 2020 |
-15.96% |
| Dec 31, 2019 |
3.83% |
| Sep 30, 2019 |
21.02% |
| Jun 30, 2019 |
-19.27% |
| Mar 31, 2019 |
9.30% |
| Dec 31, 2018 |
-30.41% |
| Sep 30, 2018 |
-22.77% |
| Jun 30, 2018 |
7.28% |
| Mar 31, 2018 |
-25.00% |
| Dec 31, 2017 |
8.87% |
| Sep 30, 2017 |
-13.77% |
| Jun 30, 2017 |
773.66% |
| Mar 31, 2017 |
-10.65% |
| Dec 31, 2016 |
-22.18% |
| Sep 30, 2016 |
-23.49% |
| Jun 30, 2016 |
79,151,843.46% |
| Mar 31, 2016 |
82,089,452.24% |
| Dec 31, 2015 |
90,722,791.57% |
| Sep 30, 2015 |
86,676,546.71% |
| Jun 30, 2015 |
-12.11% |
| Mar 31, 2015 |
-2.70% |
| Sep 30, 2014 |
-11.99% |
| Jun 30, 2014 |
1.74% |
| Mar 31, 2014 |
-3.02% |
| Sep 30, 2013 |
14.65% |
| Jun 30, 2013 |
4.80% |
| Mar 31, 2013 |
20.63% |
| Sep 30, 2012 |
29.80% |
| Jun 30, 2012 |
33.33% |
| Mar 31, 2012 |
-1.67% |
| Dec 31, 2011 |
16.64% |
| Sep 30, 2011 |
47.40% |
| Jun 30, 2011 |
27.61% |
| Mar 31, 2011 |
-88.40% |
| Dec 31, 2010 |
-100.00% |
| Sep 30, 2010 |
-90.31% |
| Jun 30, 2010 |
-88.56% |
| Mar 31, 2010 |
55.58% |
